Inhibitors of fatty acid binding protein (FABP)

The present invention relates to novel heterocyclic compounds as Fatty Acid Binding Protein ("FABP") inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity...

Full description

Saved in:
Bibliographic Details
Main Authors JOHANNES H. VOIGT, KYLE ANN SOUCY, CLIFF C. CHENG, PETER ORTH, GERALD W. SHIPPS JR, XIAOHUA HUANG, ABDELGHANI ABE ACHAB
Format Patent
LanguageEnglish
Published 20.05.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel heterocyclic compounds as Fatty Acid Binding Protein ("FABP") inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the present invention is shown below: (I)
Bibliography:Application Number: AU20090314299